We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look ...

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

On Friday, Avidity Biosciences Inc (RNA) stock saw a modest uptick, ending the day at $42.33 which represents a slight increase of $0.16 or 0.38% from the prior close of $42.17. The stock opened at ...

The Tasmanian wolf was the largest carnivorous marsupial declared extinct in the 20th century. Scientists have managed to ...

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...

Researchers at the University of Toronto and its hospital partners have developed a method for co-delivering therapeutic RNA ...

Italian startup Aptadir has launched with $1.6M to develop drugs targeting DNA hypermethylation for cancer and genetic ...

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where ...